Lactonase Activity and Lipoprotein-Phospholipase A2 as Possible Novel Serum Biomarkers for the Differential Diagnosis of Autism Spectrum Disorders and Rett Syndrome: Results from a Pilot Study
Rett syndrome (RTT) and autism spectrum disorders (ASDs) are not merely expression of brain dysfunction but also reflect the perturbation of physiological/metabolic homeostasis. Accordingly, both disorders appear to be associated with increased vulnerability to toxicants produced by redox imbalance,...
Main Authors: | Joussef Hayek, Carlo Cervellati, Ilaria Crivellari, Alessandra Pecorelli, Giuseppe Valacchi |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Oxidative Medicine and Cellular Longevity |
Online Access: | http://dx.doi.org/10.1155/2017/5694058 |
Similar Items
-
Altered Bone Status in Rett Syndrome
by: Alessandra Pecorelli, et al.
Published: (2021-06-01) -
Isoprostanes and 4-Hydroxy-2-nonenal: Markers or Mediators of Disease? Focus on Rett Syndrome as a Model of Autism Spectrum Disorder
by: Cinzia Signorini, et al.
Published: (2013-01-01) -
Antiglycative Activity and RAGE Expression in Rett Syndrome
by: Valeria Cordone, et al.
Published: (2019-02-01) -
Altered inflammasome machinery as a key player in the perpetuation of Rett syndrome oxinflammation
by: Alessandra Pecorelli, et al.
Published: (2020-01-01) -
OxInflammation: From Subclinical Condition to Pathological Biomarker
by: Giuseppe Valacchi, et al.
Published: (2018-07-01)